Vision Disorders and Phosphodiesterase Type 5 Inhibitors Alan M. Laties Review Article 20 November 2012 Pages: 1 - 18
Determinants of Under-Reporting of Adverse Drug Reactions Elena Lopez-GonzalezMaria T. HerdeiroAdolfo Figueiras Review Article 20 November 2012 Pages: 19 - 31
Safety of Rupatadine Administered Over a Period of 1 Year in the Treatment of Persistent Allergic Rhinitis Antonio ValeroFernando de la TorreIñaki Izquierdo Original Research Article 20 November 2012 Pages: 33 - 42
Use and Risk Management of Carvedilol for the Treatment of Heart Failure in the Community in England Beate Aurich-BarreraLynda V. WiltonSaad A. W. Shakir Original Research Article 20 November 2012 Pages: 43 - 54
Drug-Induced Liver Injury Network (DILIN) Prospective Study Robert J. FontanaPaul B. Watkinsthe DILIN Study Group Original Research Article 20 November 2012 Pages: 55 - 68
Platelet Measurements versus Discharge Diagnoses for Identification of Patients with Potential Drug-Induced Thrombocytopenia Maarten J. ten BergWouter W. van SolingeToine C. G. Egberts Original Research Article 20 November 2012 Pages: 69 - 76
An Intervention to Improve Spontaneous Adverse Drug Reaction Reporting by Hospital Physicians Consuelo PedrósAntoni VallanoJosep M. Arnau Original Research Article 20 November 2012 Pages: 77 - 83
Drug-Induced Thrombocytopenia Karen K. SwisherXiaoning LiJames N. George Correspondence 20 November 2012 Pages: 85 - 86